Iron Financial, LLC Abb Vie Inc. Transaction History

Iron Financial, LLC

$178 Million
Q1 2024

A detailed history of Iron Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Iron Financial, LLC holds 2,520 shares of ABBV stock, worth $412,876. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,520

Previous 2,509 0.44%

Holding current value

$412,876

Previous $388,000 18.04%

% of portfolio

0.26%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $1,758 - $2,003	11 Added 0.44%	2,520 $458,000
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $1,651 - $1,859	12 Added 0.48%	2,509 $388,000
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $32,462 - $37,579	-243 Reduced 8.87%	2,497 $372,000
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $21,996 - $27,373	-166 Reduced 5.71%	2,740 $369,000
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $2,169 - $2,498	15 Added 0.52%	2,906 $463,000

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $30,704 - $36,823	-222 Reduced 7.13%	2,891 $467,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2,549 - $2,924	19 Added 0.61%	3,113 $418,000
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $56,974 - $72,433	-414 Reduced 11.8%	3,094 $474,000
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $566,062 - $702,323	-4,289 Reduced 55.01%	3,508 $569,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $19,444 - $24,603	181 Added 2.38%	7,797 $1.06 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $121,934 - $138,413	1,146 Added 17.71%	7,616 $822,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $78,381 - $87,321	-745 Reduced 10.33%	6,470 $729,000
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $208,998 - $230,082	2,043 Added 39.5%	7,215 $781,000
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $72,923 - $98,455	-906 Reduced 14.91%	5,172 $554,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $60,738 - $71,286	707 Added 13.16%	6,078 $532,000
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $39,693 - $53,115	541 Added 11.2%	5,371 $527,000
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $9,739 - $14,766	151 Added 3.23%	4,830 $368,000
Q4 2019 Jan 30, 2020	BUY	$72.13 - $90.25 $14,353 - $17,959	199 Added 4.44%	4,679 $414,000
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $29,600 - $35,588	470 Added 11.72%	4,480 $339,000
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $8,146 - $10,413	124 Added 3.19%	4,010 $323,000
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $14,270 - $16,796	185 Added 5.0%	3,886 $313,000
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $778 - $960	-10 Reduced 0.27%	3,701 $341,000
Q3 2018 Oct 18, 2018	BUY	$88.91 - $98.84 $13,158 - $14,628	148 Added 4.15%	3,711 $351,000
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $2,872 - $3,399	32 Added 0.91%	3,563 $330,000
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $368 - $492	4 Added 0.11%	3,531 $334,000
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $19,703 - $21,606	220 Added 6.65%	3,527 $341,000
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $230,993 - $295,050	3,307	3,307 $294,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Financial, LLC with notifications on news.

Account

Iron Financial, LLC Abb Vie Inc. Transaction History